Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Slides:

Advertisements

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Advertisements

Photodynamic Laser Therapy for Lesions in the Airway

What Predicts Long-Term Survival After Heart Transplantation

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma Arianna.

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability? Tirone E. David, MD, Susan Armstrong, MS,

Usman Ahmad, MD, Haoxian Yang, MD, Camelia Sima, MD, MS, Daniel H

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Arjun Pennathur, MD, Andrew C. Chang, MD, Kevin M

Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients Arjun Pennathur, MD, James.

Induction Chemotherapy is Not Superior to a Surgery-First Strategy for Clinical N1 Non- Small Cell Lung Cancer Paul J. Speicher, MD, Zachary W. Fitch,

Castigliano M. Bhamidipati, DO, MS, George J

David T. Cooke, MD, Danh V. Nguyen, PhD, Ying Yang, MS, Steven L

Factors Predicting Recurrence and Postrecurrence Survival in Completely Resected Thymic Carcinoma Yi-Ting Yen, MD, Wu-Wei Lai, MD, Kai-Wei Chang, MD,

Loretta Erhunmwunsee, MD, Brian C

Complex Esophageal Reconstruction Procedures Have Acceptable Outcomes Compared With Routine Esophagectomy Jessica M. Moore, BS, Craig M. Hooker, PhD,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

FDA Perspective on Clinical Trial Design for Cardiovascular Devices

Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Resection of Intraabdominal Tumors With Cavoatrial Extension Using Deep Hypothermic Circulatory Arrest Christopher Lau, MD, Padraic O’Malley, MD, Mario.

Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery James Tatoulis, MD, FRACS, Rochelle Wynne, PhD,

Who Do You Say You Are? The Annals of Thoracic Surgery

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Influence of Cigarette Smoking on Survival and Tumor Invasiveness in Clinical Stage IA Lung Adenocarcinoma Ryo Maeda, MD, Junji Yoshida, MD, Genichiro.

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Is Repeat Pulmonary Metastasectomy Indicated for Soft Tissue Sarcoma?

Mallory L. Irons, MD, MBE, J. William Gaynor, MD, Thomas L

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Robert R. McMillan, MD, MPH, Camelia S. Sima, MD, MS, Nicole H

Brendon M. Stiles, MD, Mohamed K. Kamel, MD, Sebron W

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Matthew J. Bott, MD, Hanghang Wang, BA, William Travis, MD, Gregory J

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Determinants of Left Ventricular Dysfunction After Repair of Chronic Asymptomatic Mitral Regurgitation Vincent Chan, MD, MPH, Marc Ruel, MD, MPH, Elsayed.

Kathryn E. Engelhardt, MD, Malcolm M. DeCamp, MD, Anthony D

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Jonathan D. Spicer, MD, PhD, Jitesh B. Shewale, BDS, PhD, David B

Phillip G. Rowse, MD, Dawn E

Eugene Licht, MD, Arnold J. Markowitz, MD, Manjit S

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Adhering to Quality Measures in Esophagectomy Is Associated With Improved Survival in All Stages of Esophageal Cancer Pamela Samson, MD, MPHS, Varun.

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Complex Cusp Repair in Patients Undergoing the David Procedure: Is It Worth It? Hardy Baumbach, MD, Kristina Wachter, MD, Ragi Nagib, MD, Samir Ahad,

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Neoadjuvant Chemoradiation Therapy Is Beneficial for Clinical Stage T2 N0 Esophageal Cancer Patients Due to Inaccurate Preoperative Staging Jennifer.

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Steve K. Singh, MD, Gilbert H. L. Tang, MD, Manjula D

Predictors of Pleural Implants in Patients With Thymic Tumors

Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma Shinsuke.

Survival Benefits of Postoperative Chemoradiation for Lymph Node–Positive Esophageal Squamous Cell Carcinoma Po-Kuei Hsu, MD, Chien-Sheng Huang, MD,

Utilization and Outcomes of Unprotected Left Main Coronary Artery Stenting and Coronary Artery Bypass Graft Surgery Chuntao Wu, MD, PhD, Edward L. Hannan,

Alexander H. Moskovitz, MD, Nabil P

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Kathleen E. Simpson, MD, Elizabeth Pruitt, MSPH, James K

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B. Sewell, MA, Meier Hsu, MS, Kay See Tan, PhD, Hans Gerdes, MD, Pari Shah, MD, Manjit S. Bains, MD, Matthew Bott, MD, James M. Isbell, MD, David R. Jones, MD, Daniela Molena, MD The Annals of Thoracic Surgery Volume 106, Issue 1, Pages 172-177 (July 2018) DOI: 10.1016/j.athoracsur.2018.02.087 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Three-year and 5-year overall survival for patients with (N+) and without (N−) nodal disease. (CI = confidence interval; OS = overall survival.) The Annals of Thoracic Surgery 2018 106, 172-177DOI: (10.1016/j.athoracsur.2018.02.087) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Three-year and 5-year recurrence-free survival for patients with (N+) and without (N−) nodal disease. (CI = confidence interval; RFS = recurrence-free survival.) The Annals of Thoracic Surgery 2018 106, 172-177DOI: (10.1016/j.athoracsur.2018.02.087) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions